Our latest publication in Scientific Reports indicates that increasing convective flow in brain tumors via catheters, similar to convection enhanced delivery used in the clinic, will actually trigger tumor cells to invade. Luckily, this invasion can be inhibited through use of the small molecule drug AMD3100 (Plerixaflor) given systemically. This drug inhibits the receptor CXCR4 which we have previously implicated in flow-stimulated invasion (Kingsmore et al. 2016; Munson et
Returning to her college hometown, Jenny presented work completed by Kathryn Kingsmore, Chase Cornelison, and Caleb Stine at the Society for Neuro-Oncology Annual Meeting in New Orleans! Much fun to be had with science friends old and new from across the country and a lot of great science to discuss.